Herbert Tilg

71.0k total citations · 39 hit papers
452 papers, 40.3k citations indexed

About

Herbert Tilg is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Herbert Tilg has authored 452 papers receiving a total of 40.3k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Epidemiology, 95 papers in Molecular Biology and 90 papers in Immunology. Recurrent topics in Herbert Tilg's work include Liver Disease Diagnosis and Treatment (134 papers), Gut microbiota and health (48 papers) and Inflammatory Bowel Disease (47 papers). Herbert Tilg is often cited by papers focused on Liver Disease Diagnosis and Treatment (134 papers), Gut microbiota and health (48 papers) and Inflammatory Bowel Disease (47 papers). Herbert Tilg collaborates with scholars based in Austria, United States and Germany. Herbert Tilg's co-authors include Alexander R. Moschen, Arthur Kaser, Timon E. Adolph, Giovanni Targher, Christopher D. Byrne, Patrice D. Cani, Matthias Van Hul, Barbara Enrich, Willem M. de Vos and Anna Mae Diehl and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Herbert Tilg

435 papers receiving 39.5k citations

Hit Papers

Adipocytokines: mediators... 1992 2026 2003 2014 2006 2010 2022 2014 2008 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adipocytokines: mediators linking adipose tissue, inflammation and immunity
    2006 2.5k citations Herbert Tilg, Alexander R. Moschen profile →
  2. Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
    2010 1.9k citations Herbert Tilg, Alexander R. Moschen Hepatology profile →
  3. Gut microbiome and health: mechanistic insights
    2022 1.5k citations Herbert Tilg et al. Gut profile →
  4. Intestinal permeability – a new target for disease prevention and therapy
    2014 1.3k citations Herbert Tilg et al. profile →
  5. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
    2008 1.1k citations André Franke, Herbert Tilg et al. profile →
  6. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    2017 842 citations Herbert Tilg et al. Gut profile →
  7. Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
    2007 776 citations Alexander R. Moschen, Barbara Enrich et al. profile →
  8. Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
    2000 765 citations Herbert Tilg, Anna Mae Diehl profile →
  9. NAFLD and diabetes mellitus
    2016 751 citations Herbert Tilg, Alexander R. Moschen et al. profile →
  10. The intestinal microbiota fuelling metabolic inflammation
    2019 738 citations Herbert Tilg, Timon E. Adolph et al. profile →
  11. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
    2022 718 citations Antonio Gasbarrini, Herbert Tilg et al. Gut profile →
  12. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
    1994 668 citations Herbert Tilg et al. profile →
  13. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes
    2004 667 citations Barbara Enrich, Herbert Tilg et al. profile →
  14. Serum levels of cytokines in chronic liver diseases
    1992 643 citations Herbert Tilg, Manfred Herold et al. Gastroenterology profile →
  15. Gut microbiome, obesity, and metabolic dysfunction
    2011 630 citations Herbert Tilg et al. profile →
  16. Inflammatory Mechanisms in the Regulation of Insulin Resistance
    2008 604 citations Herbert Tilg, Alexander R. Moschen profile →
  17. Microbiota and diabetes: an evolving relationship
    2014 603 citations Herbert Tilg, Alexander R. Moschen Gut profile →
  18. The Intestinal Microbiota in Colorectal Cancer
    2018 552 citations Herbert Tilg, Timon E. Adolph et al. profile →
  19. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
    2020 539 citations Herbert Tilg et al. Gut profile →
  20. Antibiotics as deep modulators of gut microbiota: between good and evil
    2016 477 citations Gianluca Ianiro, Herbert Tilg et al. Gut profile →
  21. Gut-liver axis: Pathophysiological concepts and clinical implications
    2022 426 citations Herbert Tilg, Timon E. Adolph et al. profile →
  22. IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
    2018 353 citations Alexander R. Moschen, Herbert Tilg et al. profile →
  23. Gut microbiome and liver diseases
    2016 349 citations Herbert Tilg et al. Gut profile →
  24. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
    2024 349 citations Herbert Tilg et al. Gut profile →
  25. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
    2021 346 citations Herbert Tilg et al. profile →
  26. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
    2020 321 citations Herbert Tilg et al. Gut profile →
  27. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
    2021 315 citations Herbert Tilg, Timon E. Adolph et al. Nature Metabolism profile →
  28. Gut microbiome, liver immunology, and liver diseases
    2020 303 citations Herbert Tilg et al. profile →
  29. Calprotectin: from biomarker to biological function
    2021 274 citations Almina Jukic, Herbert Tilg et al. Gut profile →
  30. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
    2020 269 citations Herbert Tilg, Timon E. Adolph et al. Hepatology profile →
  31. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
    2020 255 citations Herbert Tilg et al. Gut profile →
  32. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
    2021 236 citations Herbert Tilg et al. Gut profile →
  33. The metabolic nature of inflammatory bowel diseases
    2022 184 citations Timon E. Adolph, Moritz Meyer et al. profile →
  34. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
    2022 173 citations Andreas Zollner, Robert Koch et al. Gastroenterology profile →
  35. Current therapies and new developments in NASH
    2022 128 citations Herbert Tilg et al. Gut profile →
  36. What defines a healthy gut microbiome?
    2024 122 citations Herbert Tilg et al. Gut profile →
  37. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
    2023 91 citations Christoph Grander, Felix Grabherr et al. Cardiovascular Research profile →
  38. Western diets and chronic diseases
    2024 57 citations Timon E. Adolph, Herbert Tilg Nature Medicine profile →
  39. Adipokines: masterminds of metabolic inflammation
    2024 54 citations Herbert Tilg, Gianluca Ianiro et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Herbert Tilg 18.1k 12.1k 7.6k 5.8k 5.6k 452 40.3k
Bin Gao 14.8k 0.8× 11.2k 0.9× 2.6k 0.4× 3.7k 0.6× 3.9k 0.7× 483 36.3k
Antonio Gasbarrini 15.3k 0.8× 16.9k 1.4× 8.4k 1.1× 19.9k 3.4× 2.8k 0.5× 1.8k 62.0k
David A. Brenner 26.8k 1.5× 20.1k 1.7× 4.7k 0.6× 9.0k 1.5× 4.3k 0.8× 517 59.5k
David E. Kleiner 32.1k 1.8× 8.0k 0.7× 4.2k 0.6× 7.3k 1.2× 10.5k 1.9× 515 50.7k
Anna Mae Diehl 35.4k 2.0× 13.3k 1.1× 7.6k 1.0× 8.5k 1.5× 14.6k 2.6× 407 51.5k
Frank Tacke 22.5k 1.2× 9.2k 0.8× 2.6k 0.3× 6.3k 1.1× 3.4k 0.6× 708 45.5k
Ariel E. Feldstein 17.2k 1.0× 9.2k 0.8× 4.2k 0.6× 3.8k 0.7× 6.7k 1.2× 220 26.9k
Timothy R. Billiar 7.7k 0.4× 19.5k 1.6× 12.6k 1.7× 9.4k 1.6× 1.6k 0.3× 781 57.3k
Jürgen Schölmerich 10.4k 0.6× 5.5k 0.5× 3.0k 0.4× 7.4k 1.3× 1.8k 0.3× 561 29.1k
Karine Clément 11.3k 0.6× 10.5k 0.9× 14.0k 1.8× 5.1k 0.9× 3.7k 0.7× 384 31.9k

Countries citing papers authored by Herbert Tilg

Since Specialization
Citations

This map shows the geographic impact of Herbert Tilg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Tilg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Tilg more than expected).

Fields of papers citing papers by Herbert Tilg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Tilg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Tilg. The network helps show where Herbert Tilg may publish in the future.

Co-authorship network of co-authors of Herbert Tilg

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Tilg. A scholar is included among the top collaborators of Herbert Tilg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Tilg. Herbert Tilg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fusco, William G., Timon E. Adolph, Giovanni Cammarota, et al.. (2025). Gut microbiota and atherosclerosis. Gut. gutjnl–2025. 2 indexed citations
2.
Fodor, Margot, Hannah Esser, Benno Cardini, et al.. (2024). The BAR Score Predicts and Stratifies Outcomes Following Liver Retransplantation: Insights From a Retrospective Cohort Study. Transplant International. 37. 12104–12104. 2 indexed citations
3.
Vermeire, Séverine, Laurent Peyrin‐Biroulet, Silvio Danese, et al.. (2024). DOP12 Efficacy and safety of obefazimod in UC patients at weeks 48 and 96 of an open-label maintenance study among clinical responders at week 8 of the Phase 2b induction trial. Journal of Crohn s and Colitis. 18(Supplement_1). i94–i95. 1 indexed citations
4.
Zollner, Andreas, Robert Koch, Almina Jukic, et al.. (2024). Clearance of Gut Mucosal SARS-CoV-2 Antigens and Postacute COVID-19 After 2 Years in Patients With Inflammatory Bowel Disease. Gastroenterology. 167(3). 604–607.e8. 3 indexed citations
5.
Schwärzler, Julian, Lisa Mayr, Felix Grabherr, Herbert Tilg, & Timon E. Adolph. (2024). Epithelial metabolism as a rheostat for intestinal inflammation and malignancy. Trends in Cell Biology. 34(11). 913–927. 3 indexed citations
6.
Adolph, Timon E. & Herbert Tilg. (2024). Western diets and chronic diseases. Nature Medicine. 30(8). 2133–2147. 57 indexed citations breakdown →
7.
Grander, Christoph, Felix Grabherr, & Herbert Tilg. (2023). Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Research. 119(9). 1787–1798. 91 indexed citations breakdown →
8.
Zollner, Andreas, Annika Rössler, Janine Kimpel, et al.. (2023). B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19. Viruses. 16(1). 1–1.
9.
Sapisochín, Gonzalo, Benedikt Schaefer, Herbert Tilg, et al.. (2023). Transplant oncology – Current indications and strategies to advance the field. JHEP Reports. 6(2). 100965–100965. 14 indexed citations
10.
Effenberger, Maria, Christoph Grander, Bela Hausmann, et al.. (2023). Apelin and the gut microbiome: Potential interaction in human MASLD. Digestive and Liver Disease. 56(6). 932–940. 2 indexed citations
11.
Viveiros, André, Benedikt Schaefer, Benjamin Henninger, et al.. (2021). MRI‐Based Iron Phenotyping and Patient Selection for Next‐Generation Sequencing of Non–Homeostatic Iron Regulator Hemochromatosis Genes. Hepatology. 74(5). 2424–2435. 7 indexed citations
12.
Effenberger, Maria, Andreas Kronbichler, Felix Grabherr, et al.. (2021). Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis. Journal of Medical Internet Research. 23(8). e21656–e21656. 3 indexed citations
13.
Schaefer, Benedikt, Moritz Tobiasch, André Viveiros, et al.. (2020). Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 87(5). 2256–2273. 85 indexed citations
14.
Viveiros, André, Benedikt Schaefer, Armin Finkenstedt, et al.. (2020). Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease. Liver International. 40(8). 1941–1951. 13 indexed citations
15.
Diehl, Anna Mae, Nathalie J. Farpour‐Lambert, Liping Zhao, & Herbert Tilg. (2019). Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease. Nature Metabolism. 1(11). 1027–1029. 18 indexed citations
16.
Adolph, Timon E., Felix Grabherr, Lisa Mayr, et al.. (2018). Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression. Journal of Obesity. 2018. 1–6. 15 indexed citations
17.
Tilg, Herbert & Alexander R. Moschen. (2014). Microbiota and diabetes: an evolving relationship. Gut. 63(9). 1513–1521. 603 indexed citations breakdown →
18.
Jalan, R., Roger W. Williams, Nathan Davies, et al.. (2001). Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis.. UCL Discovery (University College London). 8 indexed citations
19.
Aulitzky, Walter E., Walter E. Aulitzky, Günther Gastl, et al.. (1989). Acute Effects of Single Doses of Recombinant Interferon-γ on Blood Cell Counts and Lymphocyte Subsets in Patients with Advanced Renal Cell Cancer. Journal of Interferon Research. 9(4). 425–433. 17 indexed citations
20.
Aulitzky, Walter E., Herbert Tilg, Manfred Herold, et al.. (1988). Enhanced Serum Levels of β-2-Microglobulin, Neopterin, and Interferon-γ in Patients Treated with Recombinant Tumor Necrosis Factor-α. Journal of Interferon Research. 8(5). 655–664. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Gao Breakdown of academic impact, for papers by Antonio Gasbarrini Breakdown of academic impact, for papers by David A. Brenner Breakdown of academic impact, for papers by David E. Kleiner Breakdown of academic impact, for papers by Anna Mae Diehl Breakdown of academic impact, for papers by Frank Tacke Breakdown of academic impact, for papers by Ariel E. Feldstein Breakdown of academic impact, for papers by Timothy R. Billiar Breakdown of academic impact, for papers by Jürgen Schölmerich Breakdown of academic impact, for papers by Karine Clément
Rankless by CCL
2026